1) 3-hydroxy-3-methylglutaryl coenzyme A reductase
β-羟甲基戊二酰辅酶A还原酶
1.
Study on 3-hydroxy-3-methylglutaryl coenzyme A reductase gene polymorphism and its correlation with coronary heart disease;
β-羟甲基戊二酰辅酶A还原酶基因多态性与冠心病相关性的研究
2) HMGCOAR
β-羟基β-甲基戊二酰辅酶A还原酶
3) β-hydroxy-β-methylglutary-CoA reductase
β-羟基-β-甲基戊二酸单酰辅酶A还原酶
1.
AMP-activated protein kinase (AMPK ) is recognized as a major regulator of lipid biosynthetic pathway due to its role in the phosphorylation and inactivation of key enzymes such as acetyl-CoA carboxylase (ACC) and β-hydroxy-β-methylglutary-CoA reductase (HMGR) , as a result, triglyceride and choles.
AMPK活化可使β-羟基-β-甲基戊二酸单酰辅酶A还原酶(HMGR)、乙酰辅酶A羧化酶(ACC)等磷酸化而失去活性，从而抑制胆固醇和脂肪酸的合成。
4) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
β-羟甲基戊二酰单酰辅酶A还原酶抑制剂
5) peroxisome proliferator-actived receptors α
羟甲戊二酰辅酶A还原酶
6) 3-hydroxy 3 methylglutaryl coenzyme A reductase gene
3-羟-3甲基戊二酰辅酶A还原酶基因
补充资料：羟基甲基戊二酰辅酶A还原酶抑制剂
分子式：
CAS号：
性质：抑制HMG-CoA还原酶（EC1.1.1.88）活性的物质，如康白丁、拉伐他丁等，抑制胆固醇生物合成的重要中间体—甲羟戊酸酯的生成反应。该反应是由乙酰辅酶A合成胆固醇的限速步骤。这类抑制剂在临床上可用作降血脂和降胆固醇药以及动脉粥样硬化病预防药。
CAS号：
性质：抑制HMG-CoA还原酶（EC1.1.1.88）活性的物质，如康白丁、拉伐他丁等，抑制胆固醇生物合成的重要中间体—甲羟戊酸酯的生成反应。该反应是由乙酰辅酶A合成胆固醇的限速步骤。这类抑制剂在临床上可用作降血脂和降胆固醇药以及动脉粥样硬化病预防药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条